Zambian Preterm Birth Prevention Study
ZAPPS
Preventing Preterm Birth in Zambia
1 other identifier
observational
9,000
1 country
2
Brief Summary
This prospective non-intervention cohort study will enroll women in the first or early second trimester of pregnancy and follow them through delivery (or end of pregnancy) and 1 year postpartum. Infants will also be followed until 1 year postpartum. Detailed medical and obstetrical information will be collected, as well as biological samples, in order to better elucidate the biological mechanisms leading to preterm delivery among Zambian women, in an effort to identify new strategies for prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2015
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 6, 2016
CompletedFirst Posted
Study publicly available on registry
April 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedFebruary 17, 2026
February 1, 2026
10.2 years
April 6, 2016
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preterm Birth <37
Proportion of deliveries occurring prior to 37 weeks gestation
Measured at delivery
Secondary Outcomes (15)
Preterm Birth <34
Measured at delivery
Preterm Birth <28
Measured at delivery
Low Birth Weight
Measured at delivery
Very Low Birth Weight
Measured at delivery
Preterm prelabor rupture of membranes (PPROM)
Enrollment through delivery
- +10 more secondary outcomes
Eligibility Criteria
The study will be conducted at Kamwala Health Centre and the University Teaching Hospital, both in Lusaka, Zambia.
You may qualify if:
- Pregnant women ≥15 years will be eligible to participate. Additionally, participants will:
- Have a completed screening ultrasound with gestational age \< 20 weeks
- Be HIV-uninfected at enrollment (NB: prior to Protocol Version 4.0 \[3 Nov 2017\] enrolled both HIV-infected and uninfected women)
- Have a singleton or twin pregnancy with fetal heart tones confirmed by ultrasound
- Reside within Lusaka with no plans to relocate during the study follow-up period
- Be willing to provide written, informed consent
- Be willing to allow their infants to participate in the study
You may not qualify if:
- Pregnant women \> 24 weeks' gestation or with screening ultrasound ≥ 16 weeks
- Infants born to women not enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kamwala Health Centre
Lusaka, Zambia
University Teaching Hospital
Lusaka, Zambia
Related Publications (24)
Lawn JE, Kinney MV, Black RE, Pitt C, Cousens S, Kerber K, Corbett E, Moran AC, Morrissey CS, Oestergaard MZ. Newborn survival: a multi-country analysis of a decade of change. Health Policy Plan. 2012 Jul;27 Suppl 3:iii6-28. doi: 10.1093/heapol/czs053.
PMID: 22692417BACKGROUNDNour NM. Premature delivery and the millennium development goal. Rev Obstet Gynecol. 2012;5(2):100-5.
PMID: 22866189BACKGROUNDWang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics. 2004 Aug;114(2):372-6. doi: 10.1542/peds.114.2.372.
PMID: 15286219BACKGROUNDBlencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012 Jun 9;379(9832):2162-72. doi: 10.1016/S0140-6736(12)60820-4.
PMID: 22682464BACKGROUNDMarch of Dimes P, Save the Children, WHO. Born Too Soon: The Global Action Report on Preterm Birth. In. Edited by Eds CP Howson MK, JE Lawn. Geneva: World Health Organization; 2012.
BACKGROUNDGoldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 Jan 5;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4.
PMID: 18177778BACKGROUNDOliver RS, Lamont RF. Infection and antibiotics in the aetiology, prediction and prevention of preterm birth. J Obstet Gynaecol. 2013 Nov;33(8):768-75. doi: 10.3109/01443615.2013.842963.
PMID: 24219711BACKGROUNDGotsch F, Gotsch F, Romero R, Erez O, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, Hassan S, Yeo L. The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med. 2009;22 Suppl 2:5-23. doi: 10.1080/14767050902860690. No abstract available.
PMID: 19951079BACKGROUNDLawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet. 2005 Mar 5-11;365(9462):891-900. doi: 10.1016/S0140-6736(05)71048-5.
PMID: 15752534BACKGROUNDIams JD. Clinical practice. Prevention of preterm parturition. N Engl J Med. 2014 Jan 16;370(3):254-61. doi: 10.1056/NEJMcp1103640. No abstract available.
PMID: 24428470BACKGROUNDMuglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med. 2010 Feb 11;362(6):529-35. doi: 10.1056/NEJMra0904308. No abstract available.
PMID: 20147718BACKGROUNDKim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V, Gotsch F, Yoon BH, Chi JG, Kim JS. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol. 2010 Jul;23(7):1000-11. doi: 10.1038/modpathol.2010.73. Epub 2010 Mar 26.
PMID: 20348884BACKGROUNDMyatt L, Eschenbach DA, Lye SJ, Mesiano S, Murtha AP, Williams SM, Pennell CE; International Preterm Birth Collaborative Pathways and Systems Biology Working Groups. A standardized template for clinical studies in preterm birth. Reprod Sci. 2012 May;19(5):474-82. doi: 10.1177/1933719111426602. Epub 2012 Feb 16.
PMID: 22344727BACKGROUNDRomero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG. 2006 Dec;113 Suppl 3(Suppl 3):17-42. doi: 10.1111/j.1471-0528.2006.01120.x.
PMID: 17206962BACKGROUNDRomero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, Mazaki-Tovi S, Than NG, Hassan S, Tromp G. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG. 2006 Dec;113 Suppl 3(Suppl 3):118-35. doi: 10.1111/j.1471-0528.2006.01150.x.
PMID: 17206980BACKGROUNDLiong S, Di Quinzio MK, Fleming G, Permezel M, Rice GE, Georgiou HM. Prediction of spontaneous preterm labour in at-risk pregnant women. Reproduction. 2013 Aug 21;146(4):335-45. doi: 10.1530/REP-13-0175. Print 2013 Oct.
PMID: 23858477BACKGROUNDCox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6. doi: 10.1192/bjp.150.6.782.
PMID: 3651732BACKGROUNDWisner KL, Parry BL, Piontek CM. Clinical practice. Postpartum depression. N Engl J Med. 2002 Jul 18;347(3):194-9. doi: 10.1056/NEJMcp011542. No abstract available.
PMID: 12124409BACKGROUNDAleman A, Cafferata ML, Gibbons L, Althabe F, Ortiz J, Sandoval X, Padilla-Raygoza N, Belizan JM. Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices. Reprod Health. 2013 Jan 29;10:4. doi: 10.1186/1742-4755-10-4.
PMID: 23360713BACKGROUNDCrowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000;(2):CD000065. doi: 10.1002/14651858.CD000065.
PMID: 10796110BACKGROUNDAppiagyei A, Vwalika B, Spelke MB, Conner MG, Mabula-Bwalya CM, Kasaro MP, Honart AW, Kumwenda A, Stringer EM, Stringer JSA, Price JT. Maternal mid-upper arm circumference to predict small for gestational age: Findings in a Zambian cohort. Int J Gynaecol Obstet. 2023 May;161(2):462-469. doi: 10.1002/ijgo.14517. Epub 2022 Oct 31.
PMID: 36263879DERIVEDPrice JT, Vwalika B, Edwards JK, Cole SR, Kasaro MP, Rittenhouse KJ, Kumwenda A, Lubeya MK, Stringer JSA. Maternal HIV Infection and Spontaneous Versus Provider-Initiated Preterm Birth in an Urban Zambian Cohort. J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):860-868. doi: 10.1097/QAI.0000000000002654.
PMID: 33587508DERIVEDRittenhouse KJ, Mwape H, Nelson JAE, Mwale J, Chipili G, Price JT, Hudgens M, Stringer EM, De Paris K, Vwalika B, Stringer JSA. Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation. AIDS. 2021 Mar 15;35(4):555-565. doi: 10.1097/QAD.0000000000002808.
PMID: 33394679DERIVEDRittenhouse KJ, Vwalika B, Keil A, Winston J, Stoner M, Price JT, Kapasa M, Mubambe M, Banda V, Muunga W, Stringer JSA. Improving preterm newborn identification in low-resource settings with machine learning. PLoS One. 2019 Feb 27;14(2):e0198919. doi: 10.1371/journal.pone.0198919. eCollection 2019.
PMID: 30811399DERIVED
Related Links
Biospecimen
Blood, urine, vaginal, placental, and umbilical cord samples will be placed in a biorepository for later analysis to identify inflammatory markers, chemokines, cytokines, and infections contributing to parturition and preterm delivery.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff Stringer, MD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2016
First Posted
April 14, 2016
Study Start
August 1, 2015
Primary Completion
October 5, 2025
Study Completion (Estimated)
October 1, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02